TITLE

Warning Regarding Topical Anesthetics

PUB. DATE
February 2010
SOURCE
Internal Medicine Alert;2/15/2010 Supplement, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers updates related to pharmacology including the warning from the U.S. Food and Drug Administration (FDA) on topical anesthetics, a study which shows that antipsychotics increase sudden cardiac death and the treatment for pain, fatigue and sleep in patients with fibromyalgia.
ACCESSION #
48721717

 

Related Articles

  • Warning Regarding Topical Anesthetics. Elliott, William T. // Alternative Medicine Alert;Mar2009 Clinical Briefs in Primary, Vol. 14 Issue 3, p1 

    This section offers news briefs related to medicine as of March 2009. The U.S. Food and Drug Administration (FDA) warned the public about the life-threatening side effects of the topical anesthetics and advised them to apply only few amount of topical anesthetics over large areas of and to use...

  • The Role of Antipsychotics in the Management of Fibromyalgia. Calandre, Elena P.; Rico-Villademoros, Fernando // CNS Drugs;2012, Vol. 26 Issue 2, p135 

    Fibromyalgia is a syndrome characterized by chronic generalized pain associated with different somatic symptoms, such as sleep disturbances, fatigue, stiffness, balance problems, hypersensitivity to physical and psychological environmental stimuli, depression and anxiety. It has been estimated...

  • Meeting highlights.  // Formulary;Mar1998, Vol. 33 Issue 3, p244 

    Presents several issues highlighted at the 32nd American Society of Health-System Pharmacists' midyear meeting. Tips for switching patients to atypical antipsychotic agents; Discussion on anesthetic agents; Formulary trends in integrated health systems.

  • Amisulpride in the treatment of fibromyalgia: an uncontrolled study. Rico-Villademoros, Fernando; Rodriguez-Lopez, Carmen; Morillas-Arques, Piedad; Vilchez, Juan; Hidalgo, Javier; Calandre, Elena // Clinical Rheumatology;Sep2012, Vol. 31 Issue 9, p1371 

    Some antipsychotics, including amisulpride, have shown to be effective in the treatment of various painful conditions, lessening pain as well as symptoms of anxiety and/or depression. In this open-label, 12-week study, we explored the efficacy and tolerability of amisulpride in patients with...

  • Effects of a novel, selective, σ1-ligand, MS-377, on phencyclidine-induced behaviour. Takahashi, S.; Takagi, K.; Horikomi, K. // Naunyn-Schmiedeberg's Archives of Pharmacology;Jul2001, Vol. 364 Issue 1, p81 

    Phencyclidine (PCP)-induced head-weaving is inhibited by a novel selective σ1-ligand, (R)-(+)-1-(4-chlorophenyl)-3-[4-(2-methoxyethyl)piperazin-1-yl]methyl-2-pyrrolidinone L-tartrate (MS-377), but not by dopamine D2 antagonists. In the present study, we examined the effects of two potent and...

  • Considerations of palliative sedation therapy. Zawistowski, Christine A. // Hem/Onc Today;9/10/2008, Vol. 9 Issue 16, p36 

    The author focuses on the application of palliative sedation therapy (PST). She defines the therapy as the use of sedatives to relieve intolerable suffering from refractory symptoms by reducing the patient's consciousness. She states that the medication groups for PST are anoxiolytic, sedating...

  • Emergency anaesthetic management of a severely anaemic, chronic schizophrenic patient with history of neuroleptic malignant syndrome. Chellam, Shrividya; Rajwade, Dhanwanti S.; Tavri, Snehlata O. // Indian Journal of Anaesthesia;Nov/Dec2011, Vol. 55 Issue 6, p621 

    Administering anaesthesia to a patient with chronic schizophrenia is a challenge due to the increased risk of various perioperative complications. Neuroleptic agents are highly effective drugs used for the treatment of psychiatric disorders, but are rarely associated with neuroleptic malignant...

  • The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia NMDA receptor and schizophrenia. Coyle, Joseph T.; Tsai, Guochuan // Psychopharmacology;2004, Vol. 174 Issue 1, p32 

    Numerous clinical studies demonstrate that subanaesthetic doses of dissociative anaesthetics, which are non-competitive antagonists at the NMDA receptor, replicate in normal subjects the cognitive impairments, negative symptoms and brain functional abnormalities of schizophrenia. Post-mortem and...

  • Risperidone interaction.  // Reactions Weekly;3/20/2004, Issue 993, p12 

    Discusses research being done on the effect of risperidone during spinal anesthetic. Reference to a study by J. H. Williams and D. L. Hepner published in a January 2004 issue of "Anesthesia and Analgesia"; Condition of the patient after administration of bupivacaine, fentanyl and morphine...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics